Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, and the Intervention / Treatment heading was updated to Intervention/Treatment with a page revision tag showing v3.6.0. The recruitment status was updated to No longer looking for participants, indicating enrollment is closed.
    Difference
    0.4%
    Check dated 2026-06-12T14:27:45.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.5, indicating a backend/update of the page template. It represents a backend refresh rather than a modification to the study information displayed.
    Difference
    0.0%
    Check dated 2026-06-05T09:16:43.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.3 to v3.5.4. This reflects a new version of the page in the content management system.
    Difference
    0.0%
    Check dated 2026-05-14T23:23:43.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A revision tag on the page was updated from v3.5.2 to v3.5.3, indicating a system update; study content and displayed information remain unchanged.
    Difference
    0.0%
    Check dated 2026-04-30T18:07:01.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T11:53:40.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added the keyword 'Small cell lung carcinoma' and a new 'resources' section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T06:17:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.